about
A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against ExpeIdentification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis.Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
P2860
Q33790313-59BF369E-65E6-4B94-92ED-AC62D42441B4Q36257481-0B551934-B7DA-450D-B5E2-351C7C82264DQ37660825-10153EC8-DDAC-481D-A802-E5C14A7E4110Q37681902-768831C8-251D-49DF-A40D-44077E22CD67Q38658902-D80B00AD-42BE-48E7-91AD-3C87607A9958Q39313487-297F38B9-184F-4163-B987-C14A2CC995F9Q47201994-9D2AB3FD-C30A-4D95-A016-301726EADA84Q58705894-72EF7F49-83F2-408C-BA68-73F3DBD1F78C
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Post-Genomics and Vaccine Improvement for Leishmania
@ast
Post-Genomics and Vaccine Improvement for Leishmania
@en
Post-Genomics and Vaccine Improvement for Leishmania
@nl
type
label
Post-Genomics and Vaccine Improvement for Leishmania
@ast
Post-Genomics and Vaccine Improvement for Leishmania
@en
Post-Genomics and Vaccine Improvement for Leishmania
@nl
prefLabel
Post-Genomics and Vaccine Improvement for Leishmania
@ast
Post-Genomics and Vaccine Improvement for Leishmania
@en
Post-Genomics and Vaccine Improvement for Leishmania
@nl
P2860
P3181
P356
P1476
Post-Genomics and Vaccine Improvement for Leishmania
@en
P2093
Negar Seyed
P2860
P3181
P356
10.3389/FMICB.2016.00467
P407
P577
2016-04-06T00:00:00Z